|
Author/year | Treatment manner | Disease | Acupoint | Testing technique | Upregulation protein | Downregulation protein |
|
Bae et al./2013 [44] | Acupuncture | Kainic acid-induced neuronal destruction | HT8 (Shaofu) | 2-dimensional electrophoresis | VCP | ULMAE-1, ATPS, HSP70, HSP4L, and CRMP-2 |
|
Lai et al./2012 [45] | Acupuncture | Hypertension | LR3 | 2-dimensional electrophoresis and MALDI-TOF | Glutamate dehydrogenase 1, aldehyde dehydrogenase 2, glutathione S-transferase M5, Rho GDP dissociation inhibitor 1, DJ-1 protein, and superoxide dismutase | Heat shock protein-90, synapsin-1, pyruvate kinase isozyme, NAD-dependent deacetylase sirtuin-2, protein kinase C inhibitor protein 1, ubiquitin hydrolase isozyme L1, and myelin basic protein |
|
Gao et al./2012 [46] | Electroacupuncture | Chronic constrictive injury | ST36; GB34 | 2-dimensional electrophoresis and matrix-assisted laser desorption |
19 hippocampal proteins which are involved in metabolic, physiological, and cellular processes |
|
Pan et al./2011 [47] | Electroacupuncture | Acute ischemic stroke | MS6 (scalp acu motor areas); BL10 (Tianzhu); GB20 (Fengchi); LI4; PC6 (Neiguan); BL40 (Weizhong); SP6 (Sanyinjiao); ST36 | 2-DE + MS/MS | Gelsolin, C3 | Serpin G1 |
|
Kim et al./2010 [48] | Acupuncture | Maternal separation | HT8 | 2-dimensional electrophoresis and MALDI-TOF | Dpysl2, Drp2, Tuba1a, and Stx1b | N.A. |
|
Li et al./2010 [49] | Electroacupuncture | Spinal cord injury (SCI) | GV6 (Jizhong); GV9 (Zhiyang) | 2-dimensional electrophoresis and MALDI-TOF | ANXA5, CRMP2 | N.A. |
|
Kim et al./2010 [50] | Electroacupuncture | Parkinson’s disease | GB34; GB39 (Xuanzhong) | 2-dimensional electrophoresis and MALDI-TOF | Cytochrome coxidase, subunit Vb | HAGH, cytosolic malate dehydrogenase Munc 18-1, hydroxyacyl glutathione, and hydrolase |
|
Jeon et al./2008 [51] | Electroacupuncture | Parkinson’s disease | GB34; SI3; BL62; ST36 | 2-dimensional electrophoresis | 21 proteins | 1 protein |
|